{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:11:35Z","timestamp":1778278295313,"version":"3.51.4"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2025-0591_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Crohn\u2019s disease, which typically affects individuals of reproductive age, has risen in prevalence over the past decades. The study objective was to determine the impact of maternal Crohn\u2019s disease on maternal and neonatal adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0591_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was performed using the Healthcare Cost and Utilization Project-National Inpatient Sample from the United\u00a0States. International Classification of Diseases, 10th edition (ICD-10) codes were used to identify individuals who delivered between 2016 and 2021, and then those with Crohn\u2019s disease were identified (ICD-10 code K50). The effect of Crohn\u2019s disease on pregnancy was estimated using multivariable logistic regression adjusted for baseline maternal characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0591_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 4,337,612 births between 2016 and 2021, of which 5,671 were associated with maternal Crohn\u2019s disease, for an overall period prevalence of 13.1\/10,000 births. There was an upward trend in prevalence from 10.2\/10,000 deliveries in 2016 to 15.6\/10,000 deliveries in 2021 (p&lt;0.0001). Individuals with Crohn\u2019s disease were at increased risk of preeclampsia (odds ratio 1.6, 95\u202f% CI 1.4\u20131.7), chorioamnionitis (1.3, 1.1\u20131.5), placental abruption (1.4, 1.1\u20131.7), instrumental delivery (1.3, 1.1\u20131.4), cesarean delivery (1.6, 1.5\u20131.7), postpartum hemorrhage (1.3, 1.2\u20131.5), sepsis (2.0, 1.5\u20132.7), and venous thromboembolic events (2.1, 1.1\u20133.8). Neonates born to these mothers were more likely to be premature (1.6, 1.5\u20131.7), suffer from congenital anomalies (1.5, 1.2\u20131.8) and intrauterine growth restriction (1.7, 1.5\u20131.9).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0591_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Crohn\u2019s disease in pregnancy was associated with adverse maternal and neonatal outcomes. Pregnant patients with Crohn\u2019s disease should therefore be closely monitored throughout their pregnancy to minimize these adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2025-0591","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:57:29Z","timestamp":1771250249000},"page":"744-751","source":"Crossref","is-referenced-by-count":0,"title":["Maternal and fetal outcomes in patients with Crohn\u2019s disease: a population-based cohort study"],"prefix":"10.1515","volume":"54","author":[{"given":"Genevi\u00e8ve","family":"Lamarche","sequence":"first","affiliation":[{"name":"Faculty of Medicine , McGill University , Montreal , Quebec , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Bendayan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , McGill University , Montreal , Quebec , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-7153","authenticated-orcid":false,"given":"Haim Arie","family":"Abenhaim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Jewish General Hospital, McGill University , Montreal , Quebec , Canada"},{"name":"Centre for Clinical Epidemiology , 5620 Jewish General Hospital , Montreal , Quebec , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026050821281508341_j_jpm-2025-0591_ref_001","doi-asserted-by":"crossref","unstructured":"Torres, J, Mehandru, S, Colombel, JF, Peyrin-Biroulet, L. Crohn\u2019s disease. Lancet 2017;389:1741\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(16)31711-1.","DOI":"10.1016\/S0140-6736(16)31711-1"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_002","doi-asserted-by":"crossref","unstructured":"Chugh, R, Gaidos, JKJ. Fertility and pregnancy in Crohn\u2019s disease. Gastroenterol Clin North Am 2022;51:381\u201399. https:\/\/doi.org\/10.1016\/j.gtc.2021.12.012.","DOI":"10.1016\/j.gtc.2021.12.012"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_003","doi-asserted-by":"crossref","unstructured":"Allen, KD, Kiefer, MK, Butnariu, M, Afzali, A. Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Arch Gynecol Obstet 2022;306:1929\u201337. https:\/\/doi.org\/10.1007\/s00404-022-06463-x.","DOI":"10.1007\/s00404-022-06463-x"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_004","doi-asserted-by":"crossref","unstructured":"Gaidos, JKJ, Kane, SV. Sexuality, fertility, and pregnancy in Crohn\u2019s disease. Gastroenterol Clin North Am 2017;46:531\u201346. https:\/\/doi.org\/10.1016\/j.gtc.2017.05.007.","DOI":"10.1016\/j.gtc.2017.05.007"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_005","doi-asserted-by":"crossref","unstructured":"Mahadevan, U, Long, MD, Kane, SV, Roy, A, Dubinsky, MC, Sands, BE, et al.. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology 2021;160:1131\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.038.","DOI":"10.1053\/j.gastro.2020.11.038"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_006","doi-asserted-by":"crossref","unstructured":"Rosiou, K, Selinger, CP. Obstetric considerations in pregnant women with Crohn\u2019s disease. J\u00a0Clin Med 2023;12. https:\/\/doi.org\/10.3390\/jcm12020684.","DOI":"10.3390\/jcm12020684"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_007","doi-asserted-by":"crossref","unstructured":"Cornish, J, Tan, E, Teare, J, Teoh, TG, Rai, R, Clark, SK, et al.. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007;56:830\u20137. https:\/\/doi.org\/10.1136\/gut.2006.108324.","DOI":"10.1136\/gut.2006.108324"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_008","doi-asserted-by":"crossref","unstructured":"Friedman, S, Nielsen, J, Qvist, N, Knudsen, T, Kjeldsen, J, S\u00f8nnichsen-Dreehsen, AS, et al.. Does surgery before pregnancy in women with inflammatory bowel disease increase the risk of adverse maternal and fetal outcomes? A Danish national cohort study. Am J Gastroenterol 2024;119:1875\u201384.","DOI":"10.14309\/ajg.0000000000002732"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_009","doi-asserted-by":"crossref","unstructured":"Lee, HH, Bae, JM, Lee, BI, Lee, KM, Wie, JH, Kim, JS, et al.. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study. Aliment Pharmacol Ther 2020;51:861\u20139. https:\/\/doi.org\/10.1111\/apt.15654.","DOI":"10.1111\/apt.15654"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_010","doi-asserted-by":"crossref","unstructured":"Stephansson, O, Larsson, H, Pedersen, L, Kieler, H, Granath, F, Ludvigsson, JF, et al.. Crohn\u2019s disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 2010;8:509\u201315. https:\/\/doi.org\/10.1016\/j.cgh.2010.02.014.","DOI":"10.1016\/j.cgh.2010.02.014"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_011","doi-asserted-by":"crossref","unstructured":"Tandon, P, Govardhanam, V, Leung, K, Maxwell, C, Huang, V. Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease. Aliment Pharmacol Ther 2020;51:320\u201333. https:\/\/doi.org\/10.1111\/apt.15587.","DOI":"10.1111\/apt.15587"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_012","doi-asserted-by":"crossref","unstructured":"Prakash, P, Dua, A, Blumenfeld, Y, Chen, PH, Parian, AM, Limketkai, BN. Longitudinal trends in pregnancy outcomes among women with inflammatory bowel disease in the era of biologics: a 20-Year nationwide analysis. Inflamm Bowel Dis 2024;30:1788\u201395. https:\/\/doi.org\/10.1093\/ibd\/izad250.","DOI":"10.1093\/ibd\/izad250"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_013","doi-asserted-by":"crossref","unstructured":"Tarar, ZI, Farooq, U, Zafar, MU, Saleem, S, Nawaz, A, Kamal, F, et al.. A national study of pregnancy-related maternal and fetal outcomes in women with inflammatory bowel disease. Int J Colorectal Dis 2022;37:1535\u201343. https:\/\/doi.org\/10.1007\/s00384-022-04185-9.","DOI":"10.1007\/s00384-022-04185-9"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_014","doi-asserted-by":"crossref","unstructured":"Boyd, HA, Basit, S, Harps\u00f8e, MC, Wohlfahrt, J, Jess, T. Inflammatory bowel disease and risk of adverse pregnancy outcomes. PLoS One 2015;10. https:\/\/doi.org\/10.1371\/journal.pone.0129567.","DOI":"10.1371\/journal.pone.0129567"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_015","doi-asserted-by":"crossref","unstructured":"Abdul Sultan, A, West, J, Ban, L, Humes, D, Tata, LJ, Fleming, KM, et al.. Adverse pregnancy outcomes among women with inflammatory bowel disease: a population-based study from England. Inflamm Bowel Dis 2016;22:1621\u201330. https:\/\/doi.org\/10.1097\/mib.0000000000000802.","DOI":"10.1097\/MIB.0000000000000802"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_016","doi-asserted-by":"crossref","unstructured":"Mahadevan, U, Seow, CH, Barnes, EL, Chaparro, M, Flanagan, E, Friedman, S, et al.. Global consensus statement on the management of pregnancy in inflammatory bowel disease. Clin Gastroenterol Hepatol 2025;23:S1\u2013s60. https:\/\/doi.org\/10.1093\/ibd\/izaf171.","DOI":"10.1093\/ibd\/izaf171"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_017","doi-asserted-by":"crossref","unstructured":"Rekawek, P, Johnson, S, Bigelow, CA, Getrajdman, C, Roy-McMahon, C, Stoffels, G, et al.. Exposure to biologic therapy and associated maternal and neonatal outcomes in pregnancies complicated by inflammatory bowel disease. Am J Obstet Gynecol MFM 2022;4. https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100518.","DOI":"10.1016\/j.ajogmf.2021.100518"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_018","doi-asserted-by":"crossref","unstructured":"Clarke, LM, Hsu, S, Pant, D, James, K, Thaweethai, T, Shook, LL, et al.. The risk of hypertensive disorders of pregnancy in inflammatory bowel disease. Am J Gastroenterol 2025. https:\/\/doi.org\/10.14309\/ajg.0000000000003818.","DOI":"10.14309\/ajg.0000000000003818"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_019","doi-asserted-by":"crossref","unstructured":"Singh, M, Wambua, S, Lee, SI, Okoth, K, Wang, Z, Fayaz, FFA, et al.. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. BMC Med 2024;22:94. https:\/\/doi.org\/10.1186\/s12916-024-03309-y.","DOI":"10.1186\/s12916-024-03309-y"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_020","doi-asserted-by":"crossref","unstructured":"Hirayama, D, Hyodo, S, Morita, K, Nakase, H. Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis. J\u00a0Gastroenterol 2024;59:389\u2013401. https:\/\/doi.org\/10.1007\/s00535-024-02086-y.","DOI":"10.1007\/s00535-024-02086-y"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_021","doi-asserted-by":"crossref","unstructured":"Seow, CH, Coward, S, Kroeker, KI, Stach, J, Devitt, KS, Targownik, LE, et al.. Declining corticosteroid use for inflammatory bowel disease across Alberta: a population-based cohort study. J\u00a0Canadian Associ Gastroenterol 2022;5:276\u201386. https:\/\/doi.org\/10.1093\/jcag\/gwac021.","DOI":"10.1093\/jcag\/gwac021"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_022","doi-asserted-by":"crossref","unstructured":"Ahn, SM, Joo, YB, Kim, YJ, Bang, SY, Lee, HS. Pregnancy outcomes associated with biologic agent exposure in patients with several rheumatic diseases and inflammatory bowel diseases. J\u00a0Korean Med Sci 2023;38. https:\/\/doi.org\/10.3346\/jkms.2023.38.e172.","DOI":"10.3346\/jkms.2023.38.e172"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_023","doi-asserted-by":"crossref","unstructured":"Brandt, JS, Ananth, CV. Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management. Am J Obstet Gynecol 2023;228:S1313\u2013s1329. https:\/\/doi.org\/10.1016\/j.ajog.2022.06.059.","DOI":"10.1016\/j.ajog.2022.06.059"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_024","doi-asserted-by":"crossref","unstructured":"Garg, A, Jaiswal, A. Evaluation and management of premature rupture of membranes: a review article. Cureus 2023;15. https:\/\/doi.org\/10.7759\/cureus.36615.","DOI":"10.7759\/cureus.36615"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_025","doi-asserted-by":"crossref","unstructured":"Jain, VG, Willis, KA, Jobe, A, Ambalavanan, N. Chorioamnionitis and neonatal outcomes. Pediatr Res 2022;91:289\u201396. https:\/\/doi.org\/10.1038\/s41390-021-01633-0.","DOI":"10.1038\/s41390-021-01633-0"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_026","doi-asserted-by":"crossref","unstructured":"Payet, L, Peyronnet, V, Thouny, C, Coffin, B, Ceccaldi, PF, M\u2019Barek, IB, et al.. Impact of Crohn\u2019s disease on obstetrical management. J\u00a0Gynecol Obstet Hum Reprod 2022;51. https:\/\/doi.org\/10.1016\/j.jogoh.2022.102480.","DOI":"10.1016\/j.jogoh.2022.102480"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_027","doi-asserted-by":"crossref","unstructured":"Torres, J, Chaparro, M, Julsgaard, M, Katsanos, K, Zelinkova, Z, Agrawal, M, et al.. European Crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J\u00a0Crohns Colitis 2023;17:1\u201327. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac115.","DOI":"10.1093\/ecco-jcc\/jjac115"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_028","doi-asserted-by":"crossref","unstructured":"Operative Vaginal Birth: ACOG Practice Bulletin. Number 219. Obstet Gynecol 2020;135:e149\u201359.","DOI":"10.1097\/AOG.0000000000003764"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_029","doi-asserted-by":"crossref","unstructured":"Patek, K, Friedman, P. Postpartum hemorrhage-epidemiology, risk factors, and causes. Clin Obstet Gynecol 2023;66:344\u201356. https:\/\/doi.org\/10.1097\/grf.0000000000000782.","DOI":"10.1097\/GRF.0000000000000782"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_030","doi-asserted-by":"crossref","unstructured":"Hansen, AT, Erichsen, R, Horv\u00e1th-Puh\u00f3, E, S\u00f8rensen, HT. Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period. J\u00a0Thromb Haemost 2017;15:702\u20138. https:\/\/doi.org\/10.1111\/jth.13638.","DOI":"10.1111\/jth.13638"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_031","doi-asserted-by":"crossref","unstructured":"Kim, YH, Pfaller, B, Marson, A, Yim, HW, Huang, V, Ito, S, et al.. The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: a systematic review and meta-analysis. Medicine (Baltim) 2019;98. https:\/\/doi.org\/10.1097\/md.0000000000017309.","DOI":"10.1097\/MD.0000000000017309"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_032","doi-asserted-by":"crossref","unstructured":"Lv, X, Gao, X, Liu, J, Deng, Y, Nie, Q, Fan, X, et al.. Immune-mediated inflammatory diseases and risk of venous thromboembolism: a Mendelian randomization study. Front Immunol 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1042751.","DOI":"10.3389\/fimmu.2022.1042751"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_033","doi-asserted-by":"crossref","unstructured":"Chan, WS, Rey, E, Kent, NE, Chan, WS, Kent, NE, Rey, E, et al.. Venous thromboembolism and antithrombotic therapy in pregnancy. J\u00a0Obstet Gynaecol Can 2014;36:527\u201353. https:\/\/doi.org\/10.1016\/s1701-2163(15)30569-7.","DOI":"10.1016\/S1701-2163(15)30569-7"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_034","doi-asserted-by":"crossref","unstructured":"Auger, N, C\u00f4t\u00e9-Daigneault, J, Bilodeau-Bertrand, M, Arbour, L. Inflammatory bowel disease and risk of birth defects in offspring. J\u00a0Crohns Colitis 2020;14:588\u201394. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz211.","DOI":"10.1093\/ecco-jcc\/jjz211"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_035","doi-asserted-by":"crossref","unstructured":"Dawson, AL, Riehle-Colarusso, T, Reefhuis, J, Arena, JF, National Birth Defects Prevention Study. Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet 2014;164a:2212\u201316. https:\/\/doi.org\/10.1002\/ajmg.a.36625.","DOI":"10.1002\/ajmg.a.36625"},{"key":"2026050821281508341_j_jpm-2025-0591_ref_036","doi-asserted-by":"crossref","unstructured":"Bengtson, MB, Martin, CF, Aamodt, G, Vatn, MH, Mahadevan, U. Inadequate gestational weight gain predicts adverse pregnancy outcomes in mothers with inflammatory bowel disease: results from a prospective US pregnancy cohort. Dig Dis Sci 2017;62:2063\u20139. https:\/\/doi.org\/10.1007\/s10620-017-4547-5.","DOI":"10.1007\/s10620-017-4547-5"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0591\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0591\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:28:54Z","timestamp":1778275734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0591\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,25]]},"published-print":{"date-parts":[[2026,5,26]]}},"alternative-id":["10.1515\/jpm-2025-0591"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2025-0591","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}